1. First-line afatinib for advanced EGFRm+ NSCLC: Analysis of long-term responders in the LUX-Lung 3, 6, and 7 trials. (July 2019) Authors: Schuler, Martin; Paz-Ares, Luis; Sequist, Lecia V.; Hirsh, Vera; Lee, Ki Hyeong; Wu, Yi-Long; Lu, Shun; Zhou, Caicun; Feng, Jifeng; Ellis, Stuart H.; Samuelsen, Carl H.; Tang, Wenbo; Märten, Angela; Ehrnrooth, Eva; Park, Keunchil; Yang, James Chih-Hsin Journal: Lung cancer Issue: Volume 133(2019) Page Start: 10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P38/TF/HIF-α Signaling Pathway Participates in the Progression of CIPN in Mice. (10th July 2019) Authors: Yang, Yang; Hu, Liang; Wang, Chaoyu; Yang, Xing; Song, Ling; Jiang, Chunyi; Li, Yan; Li, Tianxi; Liu, Wen-Tao; Feng, Jifeng Other Names: Scuteri Arianna Academic Editor. Journal: BioMed research international Issue: Volume 2019(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. LncRNA HOXA11‐AS drives cisplatin resistance of human LUAD cells via modulating miR‐454‐3p/Stat3. Issue 10 (2nd September 2018) Authors: Zhao, Xia; Li, Xiaoyou; Zhou, Leilei; Ni, Jie; Yan, Wenyue; Ma, Rong; Wu, Jianzhong; Feng, Jifeng; Chen, Ping Journal: Cancer science Issue: Volume 109:Issue 10(2018) Page Start: 3068 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. MicroRNA‐339, an epigenetic modulating target is involved in human gastric carcinogenesis through targeting NOVA1. Issue 20 (29th September 2015) Authors: Shen, Bo; Zhang, Yan; Yu, Shaorong; Yuan, Yuan; Zhong, Yuejiao; Lu, Jianwei; Feng, Jifeng Journal: FEBS letters Issue: Volume 589:Issue 20(2015) Part B Page Start: 3205 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Integrated Analysis of Oncogenic Networks in Colorectal Cancer Identifies GUCA2A as a Molecular Marker. (28th July 2019) Authors: Zhang, Hui; Du, Yuanyuan; Wang, Zhuo; Lou, Rui; Wu, Jianzhong; Feng, Jifeng Other Names: Speth Robert Academic Editor. Journal: Biochemistry research international Issue: Volume 2019(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial. Issue 1 (January 2020) Authors: Yang, Yunpeng; Zhou, Jianya; Zhou, Jianying; Feng, Jifeng; Zhuang, Wu; Chen, Jianhua; Zhao, Jun; Zhong, Wei; Zhao, Yanqiu; Zhang, Yiping; Song, Yong; Hu, Yi; Yu, Zhuang; Gong, Youling; Chen, Yuan; Ye, Feng; Zhang, Shucai; Cao, Lejie; Fan, Yun; Wu, Gang Journal: Lancet Issue: Volume 8:Issue 1(2020) Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Liver X receptor agonist T0901317 inhibits the migration and invasion of non-small-cell lung cancer cells in vivo and in vitro. Issue 5 (June 2019) Authors: Lou, Rui; Cao, Haixia; Dong, Shuchen; Shi, Chen; Xu, Xiaoyue; Ma, Rong; Wu, Jianzhong; Feng, Jifeng Journal: Anti-cancer drugs Issue: Volume 30:Issue 5(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy of NEPA, a fixed antiemetic combination of netupitant and palonosetron, vs a 3‐day aprepitant regimen for prevention of chemotherapy‐induced nausea and vomiting (CINV) in Chinese patients receiving highly emetogenic chemotherapy (HEC) in a randomized Phase 3 study. (30th May 2020) Authors: Chang, Jianhua; Chen, Gongyan; Wang, Dong; Wang, Guihua; Lu, Shun; Feng, Jifeng; Li, Wei; Li, Ping; Lanzarotti, Corinna; Chessari, Salvatore; Zhang, Li Journal: Cancer medicine Issue: Volume 9:Number 14(2020) Page Start: 5134 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. New genetic variations discovered in KRAS wild‐type cetuximab resistant chinese colorectal cancer patients. Issue 5 (5th March 2020) Authors: Jing, Changwen; Wang, Ting; Ma, Rong; Cao, Haixia; Wang, Zhuo; Liu, Siwen; Chen, Dan; Zhang, Junying; Wu, Yang; Zhang, Yuan; Wu, Jianzhong; Feng, Jifeng Journal: Molecular carcinogenesis Issue: Volume 59:Issue 5(2020) Page Start: 478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Microenvironment‐induced TIMP2 loss by cancer‐secreted exosomal miR‐4443 promotes liver metastasis of breast cancer. Issue 7 (22nd January 2020) Authors: Wang, Jinyan; Zhang, Qian; Wang, Dandan; Yang, Sujin; Zhou, Siying; Xu, Hanzi; Zhang, Heda; Zhong, Shanliang; Feng, Jifeng Journal: Journal of cellular physiology Issue: Volume 235:Issue 7/8(2020) Page Start: 5722 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗